ehaweb.org
IMPACT OF BCR FUSION TRANSCRIPTS ON OUTCOMES IN ACUTE PROMYELOCYTIC LEUKEMIA (APL)
EHA Library, Venkateswar Pydi, 268322
POSTDIAGNOSIS SMOKING WITH RISK OF ALL-CAUSE AND CANCER MORTALITY AMONG LEUKEMIA SURVIVORS: A PROSPECTIVE COHORT STUDY
EHA Library, Huan Tao, 268321
THE ROLE OF ROTEM IN PREDICTING HEMORRHAGE AND HEMORRHAGIC EARLY DEATH RISK IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA
EHA Library, Nikica Sabljić, 268320
DISTRIBUTION OF BLOOD DONOR IN DIFFERENT AGE GROUP IN KATHMANDU NEPAL
EHA Library, Bipin Nepal, 268319
DISTRIBUTION OF ABO AND RH BLOOD GROUP IN NEPALESE POPULATION
EHA Library, Bipin Nepal, 268318
DYE-LIGAND CHROMATOGRAPHY AS AN ALTERNATIVE METHOD FOR OBTAINING THE FACTORS VIII/VON WILLEBRAND COMPLEX
EHA Library, Nataliya Shurko, 268317
RED CELL ALLOIMMUNIZATION IN MULTITRANSFUSED ONCOLOGY PATIENTS
EHA Library, Aisha Mahesar, 268316
REASONS FOR BLOOD DONOR DEFERRAL AMONG VOLUNTARY BLOOD DONORS IN A TERTIARY CARE HOSPITAL IN KATHMANDU, NEPAL
EHA Library, Bipin Nepal, 268315
RED CELL ALLOIMMMUNIZATION A RETROSPECTIVE SINGLE CENTRE EXPERIENCE IN AN AREA WITH A LOW INCIDENCE OF HAEMOGLOBINOPATHY:
EHA Library, Harberth Fernandez - Leyva, 268314
A STUDY OF TRANSFUSION RELATED ADVERSE EVENTS IN FAYOUM UNIVERSITY HOSPITALS, EGYPT: HEMOVIGILENCE INITIATIVE
EHA Library, Ghada Ezzat, 268313
INHERITED THROMBOPHILIA IN EGYPTIAN CHILDREN: A 13 YEAR SINGLE CENTER STUDY
EHA Library, Magy Abdelwahab, 268312
AUDIT ON NOACS (APIXABAN AND RIVAROXABAN) PRESCRIPTION IN A DISTRICT GENERAL HOSPITAL
EHA Library, Silvia Lovato, 268311
BRONCHOSCOPIC TREATMENT WITH FRESH FROZEN PLASMA AND TISSUE PLASMINOGEN ACTIVATOR FOR A CHILD WITH TYPE 1 PLASMINOGEN DEFICIENCY
EHA Library, Turkan Patıroglu, 268310
DIRECT ORAL ANTICOAGULATION IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS: A SINGLE-CENTER REAL-LIFE EXPERIENCE.
EHA Library, Simona Raso, 268309
CHARACTERISTICS OF PATIENTS WITH CANCER TREATED FOR VENOUS THROMBOEMBOLISM IN GENERAL HOSPITAL DR. JOSIP BENČEVIĆ DURING FIVE YEARS
EHA Library, Hrvoje Holik, 268308
CAN THROMBOELASTOGRAPHY (TEG) EFFECTIVELY EVALUATE COAGULATION BALANCE IN PATIENTS WITH ACUTE LEUKAEMIA UNDER CHEMOTHERAPY?
EHA Library, Simona Raso, 268307
THROMBOLYTIC THERAPY IN PEDIATRIC PATIENTS; OUTCOME AND COMPLICATIONS OF TISSUE PLASMINOGEN ACTIVATOR
EHA Library, Nazan Sarper, 268306
PLATELET GLYCOPROTEIN (GP IIB/IIIA) GENE POLYMORPHISM AS A RISK FACTOR FOR ISCHEMIC CEREBRO VASCULAR STROKE
EHA Library, Alaa Eldin Abdelhamid, 268305
PROTEIN S DEFICIENCY AND ISCHAEMIC STROKE
EHA Library, Aikaterini Kazantzi, 268304
OUTCOME AND COMPLICATIONS OF INFERIOR VENA CAVA FILTER INSERTION: TERTIARY REFERRAL CENTER EXPERIENCE.
EHA Library, Giamal Edin Gmati, 268303
POSSIBLE GENETIC RISK FACTORS OF PULMONARY EMBOLISM IN YOUNG PATIENTS FROM THE NORTH-WESTERN REGION OF RUSSIA
EHA Library, Anna Chechulova, 268302
CAROTID INTIMA-MEDIA THICKNESS PROGRESSION AND BLOOD COAGULATION FACTOR XIII LEVELS IN TYPE 2 DIABETES: 8 YEARS OF FOLLOW-UP
EHA Library, Farzaneh Sadeghi, 268301
CHANGES OF TPA AND PAI-1 IN PATIENTS WITH CORONARY ARTERY DISEASE.
EHA Library, Yuliya Tyravska, 268300
PEPTIDE CORRECTION OF OSMOTIC RESISTANCE DISORDERS IN INFLAMMATION
EHA Library, Мария Golubeva, 268290
EXPERIENCE OF TREATMENT WITH EDOXABAN IN 552 PATIENTS. SUBANALYSIS BASED ON CREATININE CLEARANCE.
EHA Library, Almudena Garcia Ruiz, 268299
REAL-WORLD EVALUATION OF BLEEDING EPISODES IN PATIENTS TREATED WITH NEWER ANTICOAGULANTS.
EHA Library, Nikolaos Neokleous, 268298
AUGMENTED AND SYNERGISTIC EFFECT OF FACTOR V LEIDEN (FVL) AND MTHFR GENES POLYMORPHISMS AND PLATELET ACTIVITY AND REACTIVITY AS RISK FACTORS FOR ISCHEMIC CEREBROVASCULAR STROKE (IS).
EHA Library, Alaa Eldin Abdelhamid, 268295
EFFICIENCY OF DUAL ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION
EHA Library, Olesia Matvienko, 268291
THE DIAGNOSTIC RELIABILITY OF TESTS DETECTION OF LUPUS ANTICOAGULANT
EHA Library, Valeriia Krasivska, 268294
INHERITED THROMBOPHILIA BY WOMEN WITH THROMBOSIS AND REPRODUCTIVE FAILURES IN ANAMNESIS
EHA Library, Anastasia Zagarskikh, 268293
INVESTIGATION OF FIBRIN MONOMER AND VON WILLEBRAND FACTOR LEVELS IN CHILDREN AFTER CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS
EHA Library, Vasilii Lastovka, 268292
Opening & welcome
EHA Library, Faculty / Presenters, 259730
Session 17: Data managers session - Data collection & LTFU - Part II
EHA Library, Sofie Terwel, 259750
Current status of CAR-T cell development in Europe and elsewhere
EHA Library, Álvaro Urbano, 261718
Issues with Centre selection and Qualification/Onboarding -- The Challenge of developing Centres of Excellence in Cell and Gene Therapy
EHA Library, Tony Pagliuca, 261168
Patients perspectives
EHA Library, Bregje Verhoeven, 261180
Patients perspectives
EHA Library, Natacha Bolanos, 261179
Issues with Centre selection and Qualification/Onboarding -- The Challenge of developing Centres of Excellence in Cell and Gene Therapy
EHA Library, Tony Pagliuca, 261178
The Dutch experience for clinical implementation of CAR T cells
EHA Library, Monique Minnema, 261177
Management of complications
EHA Library, Max Topp, 261176
The supply chain for industry-manufactured autologous CAR-T cell from a hospital perspective
EHA Library, Christian Chabannon, 261175
An introduction to CAR-T cell therapy
EHA Library, Michael Hudecek, 261163
The supply chain for industry-manufactured autologous CAR-T cell from a hospital perspective
EHA Library, Christian Chabannon, 261164
Long term follow-up after gene / cell therapy
EHA Library, JohannaB van Biezen, 261165
The Cell Therapy Form in the EBMT Registry
EHA Library, Elvira Carmen De Ruiz, 261166
The EMA Initiative on Registries
EHA Library, Eoin McGrath, 261167
An introduction to CAR-T cell therapy
EHA Library, Michael Hudecek, 261174
Patients perspectives
EHA Library, Natacha Bolanos, 261169
Patients perspectives
EHA Library, Bregje Verhoeven, 261170
Reimbursement II
EHA Library, Cornelie Haag, 261171
Evaluation & Preparation of Pediatric Patients for CAR T-Cell Treatment
EHA Library, Daphna Hutt, 261172
CAR-T cells: Lille University Hospital experience
EHA Library, Ibrahim Yakoub-Agha, 261173
Session 7: Best Abstracts & Flash Talks - Part II
EHA Library, Faculty / Presenters, 259738
Session 6: Keynote
EHA Library, Carl June, 259737
Reimbursement
EHA Library, Cornelie Haag, 261155
Celgene Cellular Therapy - Bold Innovation Delivered to Patients
EHA Library, Stanley Frankel, 261156
CAR T-cell Therapy for Childhood Solid Tumours
EHA Library, Karin Straathof, 261152
Non-Viral Genetic Engineering of Cytokine-Induced Killer (CIK) Cells with Chimeric Antigen Receptors (CARs) for the Targeting of Acute Myeloid Leukemia
EHA Library, Sarah Tettamanti, 261162
CAR-T TREATMENT FOR R/R B-CELL ALL: Experience from China
EHA Library, Peihua Lu, 261161
The Real Deal - Effectiveness, Value, & Outcomes using RWE CAR-T for ALL
EHA Library, Duane Schulthess, 261160
CD44v6 CAR-T
EHA Library, Fabio Ciceri, 261159
CART19-BE-01 trial: an update
EHA Library, Julio Delgado, 261158
CART-Ts are rolling into the clinic - the Wurzburg experience
EHA Library, Michael Hudecek, 261157
CAR T cells – a regulatory view from the EMA Committee for Advanced Therapies
EHA Library, Martina Schüssler-Lenz, 261699
Taking CAR-T from theory to reality - the Novartris experience
EHA Library, Emanuele Ostuni, 261700
New targets and technologies for CAR-T H
EHA Library, Michael Hudecek, 261154
Cars, TRUCKs and beyond: the next generation of CAR T cells
EHA Library, Hinrich Abken, 261153
Best Abstracts & Flash Talks - Part I
EHA Library, Faculty / Presenters, 259735
Chimeric Antigen Receptor T-Cell Therapy Acute Myeloid Leukemia: Targeting CD123
EHA Library, Elizabeth Budde, 261697
CAR T Cell Therapy for Multiple Myeloma
EHA Library, Andrew Garfall, 261696
How to use CAR T cells in Multiple Myeloma?
EHA Library, Hermann Einsele, 261698
Real Life Experience in the Treatment of Pediatric, Adolescent and Young Adult ALL Patients Using Commercially Avaolable CAR-T cells
EHA Library, Peter Bader, 261151
Academic CAR T cell trials for pediatric patients in Europe
EHA Library, Franco Locatelli, 261150
Improving outcomes of therapy with CAR T cells
EHA Library, Stanley Riddell, 261149
CAR T-cells in DLBCL: hype or hope
EHA Library, Marie Jose Kersten, 261148
UCL CAR T-Cell Programme - focus on CD19
EHA Library, Claire Roddie, 261147
Closing remarks
EHA Library, Faculty / Presenters, 259757
Managing CLL Patients In 2018: Updates From The Recent ASH Congress
EHA Library, Delivered by Janssen, 233813
Interpreting ASH 2017 updates for your daily clinical practice a roundtable discussion on MM
EHA Library, Delivered by Janssen, 233812
A Paradigm Shift: Emerging Therapies in Flt3-Positive AML
EHA Library, Delivered by Novartis, 224083
Expert interview with Wilma Barcellini
EHA Library, Wilma Barcellini, 226242
Expert interview with Eleni Gavriilaki
EHA Library, Eleni Gavriilaki, 226241
Expert interview with Jacqueline Boultwood
EHA Library, Jacqueline Boultwood, 226240
Expert interview with Adam Mead
EHA Library, Adam Mead, 226239
Expert interview with Jacob Odeberg
EHA Library, Jacob Odeberg, 226238
Expert interview with Valentine Brousse
EHA Library, Valentine Brousse, 226237
Expert interview with Norbert Gattermann
EHA Library, Norbert Gattermann, 226236
Expert interview with Francesco Lo Coco
EHA Library, Francesco Lo Coco, 226235
Expert interview with Francesco d'Amore
EHA Library, F D'Amore, 226234
Expert interview with Tsvee Lapidot
EHA Library, Tsvee Lapidot, 221461
Cancer and Trombosis: can we predict it?
EHA Library, Nick van Es, 221460
Listen to the patient
EHA Library, Fabio Efficace, 221459
What's new in CLL?
EHA Library, Michael Hallek, 221458
Expert interview with Carl June
EHA Library, Carl June, 221457
Expert interview with Marion Subklewe
EHA Library, Marion Subklewe, 225610
Expert interview with Sara Gorashian
EHA Library, Sara Gorashian, 225609
Expert interview with Jyoti Nangalia
EHA Library, Jyoti Nangalia, 225608
Normal and leukemic hematopoiesis in the bone marrow. Metabolic regulation in a dynamic environment
EHA Library, Tsvee Lapidot, 219244
Treating Thalassemia: Thinking 'out of the box'
EHA Library, Stefano Rivella, 219243
Amyloidosis: The rapidly changing face of diagnosis and therapy in AL amyloidosis
EHA Library, GIAMPAOLO MERLINI, 219242

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings